In the complex intracellular environment, FAM164C inhibitors exert their effects through various signaling mechanisms that are crucial for the protein's function. Kinase inhibitors, for instance, play a pivotal role in restricting the activity of FAM164C by targeting phosphorylation events, which are often essential for the activation of such proteins. Inhibition of phosphatidylinositol 3-kinase and the downstream PI3K/Akt pathway, as well as the MAPK/ERK and JNK pathways, are further examples of how cellular signaling is modulated to decrease the functional activity of FAM164C. This is achieved by selectively preventing signal transduction which may be critical for the regulation and activity of FAM164C. Similarly, inhibition of mTOR signaling impedes crucial protein synthesis and cell growth mechanisms, which could be integral to the functional regulation of FAM164C, thereby leading to its decreased activity.
Beyond kinase signaling, other inhibitors target different cellular processes that may indirectly affect the functionality of FAM164C. Agents that disrupt lysosomal acidification and autophagy pathways could lead to a reduction in FAM164C activity if it is associated with these intracellular recycling mechanisms. The inhibition of calcineurin signaling by some compounds could also potentially diminish the function of FAM164C, assuming the involvement of calcineurin in its modulation. Furthermore, the use of tyrosine kinase inhibitors suggests that if FAM164C's regulation is contingent on tyrosine kinase-mediated pathways, its activity would be reduced. Lastly, the action of a Ca2+/calmodulin-dependent protein kinase II inhibitor may lead to decreased FAM164C function, highlighting the diverse array of cellular processes that can be manipulated to inhibit the activity of this protein without the need for direct inhibition of its expression or synthesis.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
A potent kinase inhibitor that blocks phosphorylation events, which could lead to reduced activity of FAM164C if phosphorylation is critical for its activation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
A phosphatidylinositol 3-kinase inhibitor that disrupts PI3K/Akt signaling, potentially diminishing the functional activity of FAM164C if it is downstream of this pathway. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
A selective inhibitor of MEK1/2 which impairs the MAPK/ERK pathway, potentially leading to decreased function of FAM164C if it is regulated by ERK signaling. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
An mTOR inhibitor which can downregulate protein synthesis and cell growth pathways that might be involved in the functional regulation of FAM164C. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
A c-Jun N-terminal kinase inhibitor that could prevent JNK-mediated signaling processes, potentially reducing the functional activity of FAM164C if JNK signaling is involved. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
A p38 MAP kinase inhibitor, which could lead to decreased activation of FAM164C if it is modulated by p38 MAPK-dependent signaling. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
An irreversible PI3K inhibitor which could lead to functional inhibition of FAM164C by blocking PI3K-dependent signaling pathways. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
A specific inhibitor of MEK which may prevent the activation of MAPK/ERK signaling, possibly reducing the activity of FAM164C if it relies on this pathway for its function. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $96.00 $250.00 $750.00 $1428.00 | 280 | |
A V-ATPase inhibitor which disrupts lysosomal acidification and autophagy, which could lead to the functional inhibition of FAM164C if it is involved in these processes. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $62.00 $90.00 $299.00 $475.00 $1015.00 $2099.00 | 69 | |
Inhibits calcineurin, potentially reducing the activity of FAM164C if calcineurin signaling modulates its function. | ||||||